In patients with the PAP phase of COVID-19, an increase in proinflammatory cytokines, namely, IFN-α, TNF-α, G-CSF, IL17A, IL-6, IL1-β, and IL-13, has been confirmed in a number of studies [83,84,85]. This evidence concerns the gene IL17A and COVID-19.